12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Affimed completes venture financing

Affimed Therapeutics AG, Heidelberg, Germany
Business: Cancer, Inflammation, Antibodies
Date completed:...

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >